Diabetes Mellitus, Type II Clinical Trial
Official title:
Measuring Patient Engagement in Diabetes Care
| Verified date | March 2017 |
| Source | Northwestern University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
We will develop a new measure of patient engagement/activation specific to the context of diabetes self-care
| Status | Withdrawn |
| Enrollment | 0 |
| Est. completion date | December 2016 |
| Est. primary completion date | December 2016 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 21 Years and older |
| Eligibility |
Inclusion Criteria: 1. Patient is age 21 and older 2. Patient is English speaking 3. Patient has been diagnosed with Type II Diabetes by a health care provider Exclusion Criteria: 1. Severe, uncorrectable vision 2. Hearing impairments 3. Cognitive impairment |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Northwestern University | University of North Carolina |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Diabetes Self-efficacy | Self-efficacy will be assessed using an 8-item measure developed by Sarkar and colleagues asking respondents to rate their confidence in their ability to perform individual diabetes self-care activities, such as monitoring their blood glucose, getting medical attention, and taking care of their health. | Baseline | |
| Secondary | Diabetes Distress | The Diabetes Distress Scale (DDS) is a 17-item measure of diabetes-related emotional distress. It has four subscales corresponding to emotional burden, physician-related distress, regimen distress, and diabetes interpersonal distress. | Baseline | |
| Secondary | Functional Health Status | Patient-Reported Outcomes Measurement Information System (PROMIS) is a national resource providing state-of-the-art tools for assessing patient symptoms and health outcomes. Short form measures of physical health (function) and emotional health (depression, anxiety) will be collected. | Baseline | |
| Secondary | Clinical Outcomes | Hemoglobin A1c (HbA1c) and LDL cholesterol lab values, along with systolic and diastolic blood pressure values are collected as part of routine clinical care at every 3 months, and will be recorded from the medical record from the most recent visit. | 3 months before baseline to 3 months after baseline |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03596177 -
A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 Diabetes Mellitus
|
Phase 2 | |
| Completed |
NCT01728740 -
Bioequivalence Study for Acarbose / Metformin FDC
|
Phase 1 | |
| Completed |
NCT02648854 -
Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers
|
Phase 1 | |
| Recruiting |
NCT02347020 -
Impact of Sleep and Meal Timing on Food Intake Regulation
|
N/A | |
| Completed |
NCT00577590 -
Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM
|
N/A | |
| Completed |
NCT00094796 -
Rosiglitazone to Reverse Metabolic Defects in Diabetes
|
Phase 2 | |
| Completed |
NCT04830969 -
Impact of Periodontal Therapy on Patients With Diabetes
|
Phase 2 | |
| Completed |
NCT03112382 -
Effect of SLC30A8 rs13266634 Genetic Polymorphism on Zinc Supplementation and Glycemic Control in Egyptian Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
| Recruiting |
NCT01197092 -
The Effects of a Regenerative Mitochondrial Medication on Physiological Parameters in Case of Diabetes Mellitus Type II
|
Phase 2 | |
| Completed |
NCT00649909 -
Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic Patients
|
N/A | |
| Terminated |
NCT00554697 -
Diabetes Mellitus Type II and Tissue Oxygenation
|
N/A | |
| Not yet recruiting |
NCT05957224 -
Differences in Postprandial Glucose Changes
|
N/A | |
| Active, not recruiting |
NCT02088658 -
Technology Intensified Diabetes Education Study in African Americans
|
N/A | |
| Completed |
NCT00081328 -
Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)
|
Phase 3 | |
| Completed |
NCT00482079 -
A Study of MK0431 in Patients With Type 2 Diabetes (0431-010)
|
Phase 2 | |
| Recruiting |
NCT04092738 -
´Sit Less, Move More` at Work: mHealth Intervention on Office Employees With Diabetes Type 2.
|
N/A | |
| Completed |
NCT03012074 -
Episodic to Real-Time Care in Diabetes Self-Management
|
N/A | |
| Completed |
NCT02175537 -
Microclinic Social Induction Pilot Intervention for Diabetes and Obesity Management in Qatar
|
N/A | |
| Completed |
NCT01651065 -
Micro-Clinic Obesity and Metabolic Risk Prevention Program
|
N/A | |
| Completed |
NCT00528918 -
Comparison of Apidra to Regular Insulin in Hospitalized Patients
|
N/A |